Related content

The use of oral cytotoxic and cytostatic drugs in cancer treatment

By Sparreboom A.   de Jonge M.J.A.   Verweij J.  

European Journal of Cancer, Vol. 38, Iss. 1, 2002-01 ,pp. : 18-22

Elsevier

Access to resources Recommend Favorite

Oxygen metabolism in oral cancer: HIF and GLUTs (Review)

By              

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 311-316

Spandidos Publications

Access to resources Recommend Favorite

Time since last use of oral contraceptives and risk of invasive cervical cancer

By Parazzini F.   Chatenoud L.   La Vecchia C.   Chiaffarino F.   Ricci E.   Negri E.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 884-888

Elsevier

Access to resources Recommend Favorite

The effect of oral contraceptive use on the prognosis of node positive breast cancer patients

By Sauerbrei W.   Blettner M.   Schmoor C.   Bojar H.   Schumacher M.   for the German Breast Cancer Study Group  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1348-1351

Elsevier

Access to resources Recommend Favorite

Risk of breast cancer associated with short-term use of oral contraceptives

By Folger Suzanne   Marchbanks Polly   McDonald Jill   Bernstein Leslie   Ursin Giske   Berlin Jesse   Daling Janet   Norman Sandra   Strom Brian   Weiss Linda   Simon Michael   Burkman Ronald   Malone Kathleen   Spirtas Robert  

Cancer Causes and Control, Vol. 18, Iss. 2, 2007-03 ,pp. : 189-198

Springer Publishing Company

Access to resources Recommend Favorite